Zurueck zur Suche

Reporte zur Charge U031911

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

34Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
CO 14 OH 4 MI 3 PA 3 IN 2 NY 1 IL 1 IA 1 SD 1 WI 1 WA 1 NJ 1

VAERS 2320370

MERCK & CO. INC. · HEP A (VAQTA) · Charge U031911

schwer
Staat
OH
Alter
13,0
Geschlecht
M
Eingang
15.06.2022
Impfdatum
15.06.2022
Beginn
15.06.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Anxiety Crying Cyanosis Dizziness Eye movement disorder Loss of consciousness Nausea Pallor

Symptomtext

At 0930 on 6/15/2022, completed administration of immunizations to client (order Right Arm: Hep A, MenQuadfi, Left Arm: Tdap, HPV). After five seconds, client's skin color became pale, lip color turned blue, eyes rolled into head, and client lost consciousness. Client unconscious for thirty seconds before awaking. Client alert but oriented to person. Client anxious, crying. Assured client he was safe and brought mother around into client's vision better. Reclined chair back 45 degrees. Used cool compress to the temples. After five minutes of mother talking and providing touch, client stopped crying and became oriented x 4. Client stated felt dizzy and nauseous. RN gave client some time but also outlined for mother and client goals for client to drink, eat, and be steady on feet before client could leave clinic. Provided water and Graham crackers. After five minutes, client sat forward on own in chair and able to tolerate water and graham crackers. Skin color pink, lip color pink, behavior almost returned to baseline. After five minutes, client wants to attempt standing. Client stood and took five steps in room; client stated feeling dizzy. Returned client to reclined chair, encouraging client to sip water. After ten minutes, client attempts standing again. Client able to tolerate. RN and mother escort client to private vehicle.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
Cephalexin - causes lip swelling and multiple mouth sores
Vorherige Impfungen
-

VAERS 2347514

MERCK & CO. INC. · HEP A (VAQTA) · Charge U031911

mild
Staat
MI
Alter
1,0
Geschlecht
M
Eingang
01.07.2022
Impfdatum
20.06.2022
Beginn
28.06.2022
Tage bis Beginn
8,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Pyrexia

Symptomtext

>>MESSAGE (06/30/22 09:50 AM): >> Mom called and stated pt. received vaccines last week. He developed a fever on Tuesday. Tmax 104.4, but stays around 100-101 with motrin and tylenol. She was wondering whether the MMR would cause this. I spoke w/ Dr. and reviewed this online and per website "around 7 to 11 days after the injection, babies or young children may feel a bit unwell or develop a high temperature for about 2 or 3 days." Dr. recommended a covid test to be sure and to monitor for other symptoms in case it is not a vaccine reaction. Relayed this to mom and advised her to call us tomorrow if the fever has not broken. I spoke w/ mom on 7/1/22 and she stated pt.'s fever has come down to 100.3 without Tylenol or Motrin. Advised to continue to monitor. If his fever resumes or he begins not feeling well over the weekend, advised to contact our after-hours line for further instruction.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
Requested patient's mother administer a covid test to be sure this wasn't the source of the fever. Unsure if she completed this.
Aktuelle Erkrankungen
Ear pain and penile adhesions
Vorgeschichte
None
Andere Medikamente
None
Allergien
NKA
Vorherige Impfungen
-

VAERS 2269063

MERCK & CO. INC. · HEP A (VAQTA) · Charge U031911

mild
Staat
NY
Alter
1,1
Geschlecht
M
Eingang
10.05.2022
Impfdatum
25.04.2022
Beginn
09.05.2022
Tage bis Beginn
14,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Pallor Rash Rash maculo-papular Skin lesion

Symptomtext

Pt presented on 5/9/22 with rash to torso, face, trunk, plantar surface. Started on 5/9/22 am, on trunk that spread. Not painful nor itchy. Rash blanches with pressure; maculopapular lesions with lighter halo, different sizes. No vesicular lesions.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
Sinusitis, URI
Vorgeschichte
adenoidectomy and b/l myringotomy tubes
Andere Medikamente
None
Allergien
NKDA, NKA
Vorherige Impfungen
-

VAERS 2724028

MERCK & CO. INC. · HEP A (VAQTA) · Charge U031911

gering
Staat
IL
Alter
19,0
Geschlecht
M
Eingang
14.12.2023
Impfdatum
11.03.2022
Beginn
11.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Underdose

Symptomtext

No adverse event; an adult patient being administered a pediatrics dose of VAQTA/underimmunized - pediatric HepA administered instead of adult HepA; Indicate at which point in the process the medication error occurred: prescribing and administration; # of previous doses: 2 - was repeating series due to stem cell transplant/pre-xisting physician diagnosed medical condition: history of allogenic stem cell transplant requiring re-vaccination; This spontaneous report was received from a nurse refers to a 19-year-old male patient. The patient's concurrent condition included ill-defined disorder (reported as: hgb s-s disease) and chronic kidney disease. The patient's medical history included allogenic stem cell transplantation (reported as: history of allogenic stem cell transplantation + requiring re-vaccination), thrombosis and exposure to radiation. The patient's concomitant medication was not reported. On 11-MAR-2022, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) lot # U031911, expiration date: 11-NOV-2022, 0.5 milliliter in the right deltoid (route of administration was not reported) for prophylaxis. It was reported that, on 11-MAR-2022, adult patient received a pediatric dose of hepatitis a vaccine, inactivated (VAQTA) (incorrect dose administered). It was indicated that the process of the medication error occurred in prescribing and administration (product prescribing error). Number of previous doses was provided as 2. The patient was repeating series due to stem cell transplant (extra dose administered). No additional adverse event reported (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Allogenic stem cell transplantation (History of allogenic stem cell transplantation + requiring re-vaccination); Chronic kidney disease; Exposure to radiation (History of radiation exposure); Ill-defined disorder (hgb s-s disease); Thrombosis (History of thrombus)
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2574227

MERCK & CO. INC. · HEP A (VAQTA) · Charge U031911

gering
Staat
CO
Alter
-
Geschlecht
U
Eingang
17.02.2023
Impfdatum
30.01.2023
Beginn
30.01.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional adverse event reported; Medical assistant reports patient was accidently administered an expired dose of VAQTA on 30-JAN-2023; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's concurrent conditions, drug reactions or allergies, pertinent medical history and concomitant therapies were not reported. On 30-JAN-2023, the patient was accidently administered with an expired dose of hepatitis a vaccine, inactivated (VAQTA), lot # U031911, expiration date 11-NOV-2022, for prophylaxis (dose and route were not reported) (expired product administered). Product had no prior temperature excursions. No additional adverse event and not product quality complaint were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2574227

MERCK & CO. INC. · HEP A (VAQTA) · Charge U031911

gering
Staat
CO
Alter
-
Geschlecht
U
Eingang
17.02.2023
Impfdatum
30.01.2023
Beginn
30.01.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional adverse event reported; Medical assistant reports patient was accidently administered an expired dose of VAQTA on 30-JAN-2023; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's concurrent conditions, drug reactions or allergies, pertinent medical history and concomitant therapies were not reported. On 30-JAN-2023, the patient was accidently administered with an expired dose of hepatitis a vaccine, inactivated (VAQTA), lot # U031911, expiration date 11-NOV-2022, for prophylaxis (dose and route were not reported) (expired product administered). Product had no prior temperature excursions. No additional adverse event and not product quality complaint were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2580038

MERCK & CO. INC. · HEP A (VAQTA) · Charge U031911

gering
Staat
CO
Alter
-
Geschlecht
U
Eingang
13.02.2023
Impfdatum
15.11.2022
Beginn
15.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE reported.; Medical assistant reports patient was accidently administered an expired dose of VAQTA on Nov 15, 2022. Product expired on Nov 11, 2022. Product had no prior temperature excursions. No further information provided. No additional AE reported. No PQC r; This spontaneous report was received from an other health professional (Medical assistant) and referred to a patient of unknown age and gender. The patient's concomitant medications, pertinent medical history and drug reactions/allergies were not reported. On 15-NOV-2022, the patient was accidently administered an expired dose of hepatitis a vaccine, inactivated (VAQTA) intramuscular injection (once, lot #U031911, expiration date: 11-NOV-2022, dose, strength, anatomical location and route of administration were not provided) administered for prophylaxis (Expired product administered). Product had no prior temperature excursions. No further information provided. No additional adverse event (AE) reported (No adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2574231

MERCK & CO. INC. · HEP A (VAQTA) · Charge U031911

gering
Staat
CO
Alter
-
Geschlecht
U
Eingang
10.02.2023
Impfdatum
27.01.2023
Beginn
27.01.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE reported; Medical assistant reports patient was accidently administered an expired dose of VAQTA on Jan 27, 2023. Product expired on Nov 11, 2022; This spontaneous report has been received from a medical assistant concerning a patient of unknown age and gender. The patient's concurrent conditions, medical history, concomitant therapies and drug/allergy history were not reported. On 27-JAN-2023, the patient was vaccinated with an expired dose of hepatitis a vaccine, inactivated (VAQTA) (lot # U031911, has been verified to be a valid lot number for hepatitis a vaccine, inactivated [VAQTA], expiration date reported and upon internal validation established as 11-NOV-2022) for prophylaxis (dose, anatomical location and route of administration were not reported) (Expired product administered). The vaccine did not have prior temperature excursions. No additional adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2574231

MERCK & CO. INC. · HEP A (VAQTA) · Charge U031911

gering
Staat
CO
Alter
-
Geschlecht
U
Eingang
10.02.2023
Impfdatum
27.01.2023
Beginn
27.01.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE reported; Medical assistant reports patient was accidently administered an expired dose of VAQTA on Jan 27, 2023. Product expired on Nov 11, 2022; This spontaneous report has been received from a medical assistant concerning a patient of unknown age and gender. The patient's concurrent conditions, medical history, concomitant therapies and drug/allergy history were not reported. On 27-JAN-2023, the patient was vaccinated with an expired dose of hepatitis a vaccine, inactivated (VAQTA) (lot # U031911, has been verified to be a valid lot number for hepatitis a vaccine, inactivated [VAQTA], expiration date reported and upon internal validation established as 11-NOV-2022) for prophylaxis (dose, anatomical location and route of administration were not reported) (Expired product administered). The vaccine did not have prior temperature excursions. No additional adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2574296

MERCK & CO. INC. · HEP A (VAQTA) · Charge U031911

gering
Staat
CO
Alter
-
Geschlecht
U
Eingang
09.02.2023
Impfdatum
30.01.2023
Beginn
30.01.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

No additional AE reported; patient was accidently administered an expired dose of VAQTA on Jan 30, 2023; This spontaneous report was received from a medical assistant and refers to a patient of unspecified age and gender. The patient's concomitant medications, pertinent medical history, concurrent conditions, drug reactions or allergies were not reported. On 30-JAN-2023, the patient was vaccinated with expired dose of hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, once, lot #U031911, expiration date: 11-NOV-2022, administered for prophylaxis (strength, dose, site and route of administration were not provided) for prophylaxis (Expired product administered). The product had no prior temperature excursions. No additional adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2574296

MERCK & CO. INC. · HEP A (VAQTA) · Charge U031911

gering
Staat
CO
Alter
-
Geschlecht
U
Eingang
09.02.2023
Impfdatum
30.01.2023
Beginn
30.01.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

No additional AE reported; patient was accidently administered an expired dose of VAQTA on Jan 30, 2023; This spontaneous report was received from a medical assistant and refers to a patient of unspecified age and gender. The patient's concomitant medications, pertinent medical history, concurrent conditions, drug reactions or allergies were not reported. On 30-JAN-2023, the patient was vaccinated with expired dose of hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, once, lot #U031911, expiration date: 11-NOV-2022, administered for prophylaxis (strength, dose, site and route of administration were not provided) for prophylaxis (Expired product administered). The product had no prior temperature excursions. No additional adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2574228

MERCK & CO. INC. · HEP A (VAQTA) · Charge U031911

gering
Staat
CO
Alter
-
Geschlecht
U
Eingang
09.02.2023
Impfdatum
27.01.2023
Beginn
27.01.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

No additional AE reported; patient was accidently administered an expired dose of VAQTA; This spontaneous report has been received from medical assistant concerning a patient of unknown age and gender. Their concurrent conditions, medical history, drug reactions/allergies, and concomitant medications were not provided. On 27-JAN-2023, the patient was accidentally vaccinated with an expired dose of Hepatitis A Vaccine, Inactivated (VAQTA) administered as prophylaxis, lot number U031911 with expiration date 11-NOV-2022 (Expired product administered). The vaccine had no prior temperature excursions. No additional adverse events were reported (No adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2574228

MERCK & CO. INC. · HEP A (VAQTA) · Charge U031911

gering
Staat
CO
Alter
-
Geschlecht
U
Eingang
09.02.2023
Impfdatum
27.01.2023
Beginn
27.01.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

No additional AE reported; patient was accidently administered an expired dose of VAQTA; This spontaneous report has been received from medical assistant concerning a patient of unknown age and gender. Their concurrent conditions, medical history, drug reactions/allergies, and concomitant medications were not provided. On 27-JAN-2023, the patient was accidentally vaccinated with an expired dose of Hepatitis A Vaccine, Inactivated (VAQTA) administered as prophylaxis, lot number U031911 with expiration date 11-NOV-2022 (Expired product administered). The vaccine had no prior temperature excursions. No additional adverse events were reported (No adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2574225

MERCK & CO. INC. · HEP A (VAQTA) · Charge U031911

gering
Staat
CO
Alter
-
Geschlecht
U
Eingang
09.02.2023
Impfdatum
26.01.2023
Beginn
26.01.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

No additional AE reported; Medical assistant reports patient was accidently administered an expired dose of VAQTA on Jan 26, 2023; This spontaneous report was received from a registered medical assistant and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 26-JAN-2023, the patient was accidently vaccinated with an expired dose of hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, once, lot #U031911, expiration date: 11-NOV-2022 (expired product administered), administered for prophylaxis (strength, exact dose and route of administration were not provided). The vaccine had no prior temperature excursions. No additional adverse event (AE) was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2574225

MERCK & CO. INC. · HEP A (VAQTA) · Charge U031911

gering
Staat
CO
Alter
-
Geschlecht
U
Eingang
09.02.2023
Impfdatum
26.01.2023
Beginn
26.01.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

No additional AE reported; Medical assistant reports patient was accidently administered an expired dose of VAQTA on Jan 26, 2023; This spontaneous report was received from a registered medical assistant and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 26-JAN-2023, the patient was accidently vaccinated with an expired dose of hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, once, lot #U031911, expiration date: 11-NOV-2022 (expired product administered), administered for prophylaxis (strength, exact dose and route of administration were not provided). The vaccine had no prior temperature excursions. No additional adverse event (AE) was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2574276

MERCK & CO. INC. · HEP A (VAQTA) · Charge U031911

gering
Staat
CO
Alter
-
Geschlecht
U
Eingang
08.02.2023
Impfdatum
30.01.2023
Beginn
30.01.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE reported; Patient was accidently administered an expired dose of VAQTA on Jan 30, 2023. Product expired on Nov 11, 2022; This spontaneous report has been received from a medical assistance, concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions, historical drugs, and concomitant therapies were not reported. On 30-JAN-2023, the patient was vaccinated with an expired dose of hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, once (lot number U031911 has been verified to be valid for hepatitis a vaccine, inactivated (VAQTA), expiration date reported and confirmed as 11-NOV-2022), administered as prophylaxis (exact dose, route of administration, and anatomical location were not provided) (Expired product administered). The vaccine administered had no prior temperature excursions. No further information provided. No additional adverse event (AE) was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2574276

MERCK & CO. INC. · HEP A (VAQTA) · Charge U031911

gering
Staat
CO
Alter
-
Geschlecht
U
Eingang
08.02.2023
Impfdatum
30.01.2023
Beginn
30.01.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE reported; Patient was accidently administered an expired dose of VAQTA on Jan 30, 2023. Product expired on Nov 11, 2022; This spontaneous report has been received from a medical assistance, concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions, historical drugs, and concomitant therapies were not reported. On 30-JAN-2023, the patient was vaccinated with an expired dose of hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, once (lot number U031911 has been verified to be valid for hepatitis a vaccine, inactivated (VAQTA), expiration date reported and confirmed as 11-NOV-2022), administered as prophylaxis (exact dose, route of administration, and anatomical location were not provided) (Expired product administered). The vaccine administered had no prior temperature excursions. No further information provided. No additional adverse event (AE) was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2574222

MERCK & CO. INC. · HEP A (VAQTA) · Charge U031911

gering
Staat
CO
Alter
1,0
Geschlecht
F
Eingang
02.02.2023
Impfdatum
15.11.2022
Beginn
15.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered No adverse event

Symptomtext

Patient was given vaccine past the expiration date. No adverse reactions.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2547937

MERCK & CO. INC. · HEP A (VAQTA) · Charge U031911

gering
Staat
IN
Alter
-
Geschlecht
U
Eingang
02.01.2023
Impfdatum
28.12.2022
Beginn
28.12.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

No additonal AE's; A nurse reported that an expired dose of VAQTA pediatric vaccine was administered to a patient.; This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies, or medical history provided. On 28-DEC-2022, the patient was vaccinated with expired dose of pediatric hepatitis a vaccine, inactivated (VAQTA) 25U intramuscular injection, lot #U031911 has been verified to be valid, expiration date was reported as 11-NOV-2022 for prevention of hepatitis A infection (dose, anatomical location, and route of administration were not provided) (expired product administered).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2527250

MERCK & CO. INC. · HEP A (VAQTA) · Charge U031911

gering
Staat
IA
Alter
-
Geschlecht
U
Eingang
09.12.2022
Impfdatum
21.11.2022
Beginn
21.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

no additional AE's; The caller states that a pediatric patient was administered an expired dose of VAQTA; This spontaneous report has been received from a nurse, regarding to a child patient (also reported as pediatric person) of unknown age and gender. The patient's pertinent medical history, concomitant medications, concurrent conditions, and previous drug reactions or allergies were not reported. On 21-NOV-2022, the patient was vaccinated with an expired dose of with hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, (lot number: U031911, which was determined to be valid, with an expiration date on 11-NOV-2022) (strength, dose, route of administration, and anatomical site of injection were not reported) (expired product administered). No additional adverse events were reported in the patient.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2526039

MERCK & CO. INC. · HEP A (VAQTA) · Charge U031911

gering
Staat
OH
Alter
1,1
Geschlecht
U
Eingang
08.12.2022
Impfdatum
15.11.2022
Beginn
15.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE details; A patient was administered a dose of VAQTA past it's expiration date; This spontaneous report was received from a health business professional referring to a 13-month-old (reported as 1 year and 1 month) patient of unspecified gender. Information regarding the patient's medical history, concurrent conditions, concomitant therapies and previous drug reactions or allergies was not provided. On 15-NOV-2022, the patient was vaccinated with an expired dose of hepatitis A vaccine, inactivated (VAQTA) as prophylaxis (dose, route of administration, and anatomical site of vaccination were not reported; lot number U031911 has been verified to be valid, expiration date reported and established as 11-NOV-2022) (expired product administered). No additional adverse event reported (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2525541

MERCK & CO. INC. · HEP A (VAQTA) · Charge U031911

gering
Staat
IN
Alter
1,5
Geschlecht
F
Eingang
07.12.2022
Impfdatum
14.11.2022
Beginn
14.11.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LG
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered No adverse event

Symptomtext

No adverse event. Vaccine expired on 11/11/2022 while vaccine was given on 11/14/2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2522215

MERCK & CO. INC. · HEP A (VAQTA) · Charge U031911

gering
Staat
PA
Alter
-
Geschlecht
U
Eingang
02.12.2022
Impfdatum
23.11.2022
Beginn
23.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

Nurse reporting VAQTA was administered after expiration. No additional AE. No PQC.; Nurse reporting VAQTA was administered after expiration. No additional AE. No PQC.; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies, or concomitant therapies was provided. On 23-NOV-2022, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) (lot # U031911, expiration date: 11-NOV-2022, 0.5 ml, strength and route of administration were unknown) for prophylaxis after expiration (expired product administered). No additional adverse event (AE) was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2521326

MERCK & CO. INC. · HEP A (VAQTA) · Charge U031911

gering
Staat
PA
Alter
-
Geschlecht
U
Eingang
02.12.2022
Impfdatum
23.11.2022
Beginn
23.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

No additional AE; Nurse reporting VAQTA was administered after expiration. No additional AE. No PQC.; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. Information regarding the patient medical history, concomitant medications, drug allergies or reactions was not provided. On 23-NOV-2022, the patient was vaccinated with an expired dose of hepatitis a vaccine, inactivated (VAQTA), 0.5 milligram, lot # U031911 expiry date 11-NOV-2022, for prophylaxis (expired product administered) (dose number frequency and administration route was not provided) .

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2514637

MERCK & CO. INC. · HEP A (VAQTA) · Charge U031911

gering
Staat
SD
Alter
-
Geschlecht
U
Eingang
23.11.2022
Impfdatum
17.11.2022
Beginn
17.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE; HCP is reporting an expired dose of VAQTA (Lot: U031911, Expiration Date 11NOV2022) was administered to a patient.; This spontaneous report has been received from a nurse concerning a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, drugs reactions or allergies and concomitant medications were not provided. On 17-NOV-2022, the patient was vaccinated with an expired dose of hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, 0.5 milliliters (mL) once (valid lot number U031911 with an expiration date on 11-NOV-2022) (strength, frequency, route of administration and anatomical injection site were not provided) for prophylaxis (expired product administered). No additional adverse event (AE) was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2513993

MERCK & CO. INC. · HEP A (VAQTA) · Charge U031911

gering
Staat
OH
Alter
1,1
Geschlecht
F
Eingang
22.11.2022
Impfdatum
15.11.2022
Beginn
21.11.2022
Tage bis Beginn
6,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered

Symptomtext

On 11/15/2022 Pt was given Hepatitis A that expired on 11/11/2022

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
NKA
Vorherige Impfungen
-

VAERS 2423734

MERCK & CO. INC. · HEP A (VAQTA) · Charge U031911

gering
Staat
PA
Alter
-
Geschlecht
U
Eingang
30.08.2022
Impfdatum
18.08.2022
Beginn
18.08.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administration error

Symptomtext

No additional adverse events; patient did not receive full dose of VAQTA; inexperienced nurse who administered the dose and because of "user error"; This spontaneous report was received from a licensed practical nurse concerning a patient of unknown age and gender. The patient's concurrent conditions, medical history, drug reactions/allergies, and concomitant medications were not provided. On 18-AUG-2022, the patient was vaccinated with a dose of Hepatitis A Vaccine, Inactivated (VAQTA) pre-filled syringe (dosage regimen and route of administration were not reported) lot number U031911, expiration date: 11-NOV-2022, administered as prophylaxis. The nurse reported that it was the inexperienced nurse who administered the dose and because of "user error" (Product administration error), part of the dose was sprayed on the floor and part in the vaccine; therefore, the patient did not receive the full dose of Hepatitis A Vaccine, Inactivated (VAQTA) (Underdose). No additional adverse events were reported (No adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administration error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2369856

MERCK & CO. INC. · HEP A (VAQTA) · Charge U031911

gering
Staat
WI
Alter
-
Geschlecht
U
Eingang
15.07.2022
Impfdatum
16.06.2022
Beginn
16.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AEs; Caller reported vaccines administered after temperature excursion; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's pertinent medical history, current conditions, drug reactions or allergies and concomitant medications were not reported. On 16-JUN-2022, the patient was vaccinated with improperly stored doses of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (recombinant human albumin) (M-M-R II) subcutaneous injection, 0.5 milliliter, lot #U025200 was confirmed to be valid, expiration date: 13-AUG-2023, administered subcutaneously (reported as "SQ") (strength and site of administration were not provided) and hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, 0.5 milliliter, lot #U031911 was confirmed to be valid, expiration date: 11-NOV-2022, administered intramuscularly (reported as "IM") both for prophylaxis (strength and site of administration were not provided). Both vaccines were exposed to the temperature of 13.5 degrees Celsius for 10 minutes (product storage error). No previous temperature excursions were reported. No additional adverse events or product quality complaints were reported (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2359166

MERCK & CO. INC. · HEP A (VAQTA) · Charge U031911

gering
Staat
MI
Alter
-
Geschlecht
U
Eingang
06.07.2022
Impfdatum
29.06.2022
Beginn
29.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

the patient had no symptoms or adverse events following administration; nurse who reports administration of vaccines following temperature excursion.; This spontaneous report has been received from a nurse referring to a patient of an unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications, and previous drug allergies or reactions were not provided. On 29-JUN-2022, the patient was vaccinated with a improperly stored hepatitis a vaccine, inactivated (VAQTA) at a dose of 0.5ml/once, lot number U031911, expiration date: 11-NOV-2022, as prophylaxis (strength, vaccination scheme, and route of administration were not provided) following a temperature excursion of minus 0.8 degrees Celsius (C) for 1 hour 10 minutes, there was stated that no previous temperature excursion occurred. The patient had no symptoms or adverse events following administration of the vaccine. This is one of several cases from the same reporter.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2359146

MERCK & CO. INC. · HEP A (VAQTA) · Charge U031911

gering
Staat
OH
Alter
-
Geschlecht
U
Eingang
06.07.2022
Impfdatum
13.06.2022
Beginn
13.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Medical assistant calling to report administered vaccine temperature excursion on multiple patients. Per caller vaccines went out of range yesterday and it was not discovered until this morning when checking the data logger.; This spontaneous report was received from a medical asssistant (also reported as physician, conflicting information) referring to a patient of unknown age and gender. No information was provided regarding the patient's pertinent medical history, concomitant medications, concurrent conditions, and previous drug reactions or allergies. On 13-JUN-2022, the patient was vaccinated with improperly stored dose of hepatitis A vaccine, inactivated (VAQTA) (1 injection; lot #U031911; expiration date: 11-NOV-2022; strength, and route of administration were not provided), administered for prophylaxis (Product storage error). Administered vaccine experienced the temperature excursion. It was reported that vaccines went out of range on 13-JUN-2022 (reported as yesterday) and it was not discovered until 14-JUN-2022 (reported as this morning) when checking the data logger. This is one of several reports received from the same reporter. ; Sender's Comments: US-009507513-2206USA004337: US-009507513-2206USA004154: US-009507513-2206USA004511: US-009507513-2206USA004187: US-009507513-2206USA004506:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2307077

MERCK & CO. INC. · HEP A (VAQTA) · Charge U031911

gering
Staat
WA
Alter
1,0
Geschlecht
M
Eingang
02.06.2022
Impfdatum
24.05.2022
Beginn
24.05.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Inappropriate schedule of product administration No adverse event

Symptomtext

12 month old patient given proquad with varicella in single presentation. No symptoms or adverse outcomes.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
none
Allergien
NKA
Vorherige Impfungen
-

VAERS 2294391

MERCK & CO. INC. · HEP A (VAQTA) · Charge u031911

gering
Staat
NJ
Alter
2,0
Geschlecht
F
Eingang
25.05.2022
Impfdatum
19.05.2022
Beginn
25.05.2022
Tage bis Beginn
6,0
Dosis
2
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration

Symptomtext

Patient was given the 2nd HEP A vaccine too soon. Patient mother informed to check for unusa

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 2286357

MERCK & CO. INC. · HEP A (VAQTA) · Charge U031911

gering
Staat
MN
Alter
-
Geschlecht
U
Eingang
20.05.2022
Impfdatum
16.05.2022
Beginn
16.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered

Symptomtext

Customer calling to report that an adult patient was administered a pediatric dose of VAQTA.; This spontaneous report has been received from a nurse concerning an adult patient of unreported age and gender. The patient's pertinent medical history, concurrent conditions, previous drug reactions or allergies, and concomitant medications were not provided. On 16-MAY-2022, the patient was vaccinated with a pediatric dose of hepatitis a vaccine, inactivated (VAQTA) (lot number U031911 and expiration date 11-NOV-2022, was verified to be a valid lot number) (strength, dose, frequency, anatomical injection site, were not provided) for prophylaxis (incorrect dose administered). No other issues or concerns were noted.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2275739

MERCK & CO. INC. · HEP A (VAQTA) · Charge U031911

gering
Staat
MI
Alter
1,5
Geschlecht
F
Eingang
13.05.2022
Impfdatum
10.05.2022
Beginn
10.05.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Inappropriate schedule of product administration

Symptomtext

NO ADVERSE EFFECTS-JUST AN ERROR. GIVEN 8 DAYS EARLY

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
NA
Allergien
NA
Vorherige Impfungen
-